GlassScriptPhysician profile
Elle Porteous
NPI 1861089500
$2,884.41
in general payments reported to CMS, 2019-2025
24 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.47 · 2022: $488 · 2023: $1,597 · 2024: $660 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $493.73 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.63 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $276.32 | 2023-2024 | Watchman Access System, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $249.71 | 2022-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $216.42 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Kestra Medical Technology Services, INC. | $174.81 | 2023 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $169.83 | 2021-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $148.41 | 2022-2023 | Arcalyst |
| Amgen INC. | $127.52 | 2022-2023 | Repatha |
| Abbott Laboratories | $114.51 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jeti All In One Non-Sterile Kit, Aveir |
| Shockwave Medical, INC | $104.55 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $83.93 | 2023-2024 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $60.85 | 2024 | Arcalyst |
| Pfizer INC. | $60.83 | 2022-2024 | |
| Scpharmaceuticals INC. | $34.64 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $33.24 | 2024 | Auryon Laser System 100-120 Vac |
| Irhythm Technologies, INC. | $31.20 | 2023 | Zio Xt Patch |
| Cardiva Medical, INC. | $24.04 | 2023 | Cardiva Vascade 6/7f Vcs |
| Novo Nordisk INC | $23.44 | 2024 | Wegovy |
| Philips North America LLC | $18.80 | 2023 | |
| Daiichi Sankyo INC. | $18.59 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $17.44 | 2024 | Verquvo |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Baxter Healthcare | $14.97 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elle Porteous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.